Go Pro
NYSE:DGX

Quest Diagnostics Q2 2026 Earnings Report

Quest Diagnostics logo
$206.59 -1.07 (-0.51%)
Closing price 03:59 PM Eastern
Extended Trading
$206.80 +0.21 (+0.10%)
As of 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Quest Diagnostics EPS Results

Actual EPS
N/A
Consensus EPS
$2.81
Beat/Miss
N/A
One Year Ago EPS
N/A

Quest Diagnostics Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.97 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Quest Diagnostics Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Thursday, July 23, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Quest Diagnostics Earnings Headlines

Quest Diagnostics (NYSE:DGX) Rating Lowered to "Hold" at Wall Street Zen
Quest Diagnostics (DGX) Expected to Release Earnings on Thursday
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
Quest Diagnostics's Q2 2026 Earnings: What to Expect
See More Quest Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Quest Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your email.

About Quest Diagnostics

Quest Diagnostics (NYSE:DGX) (NYSE: DGX) is a leading provider of diagnostic information services that supports clinical decision-making for patients, physicians and healthcare organizations. The company operates a network of clinical laboratories and patient service centers that perform a broad range of laboratory tests and diagnostic assays used in routine care, disease diagnosis, monitoring and screening.

Its services span core clinical laboratory testing, anatomic pathology, molecular and genomic diagnostics, infectious disease testing and toxicology. Quest also offers specialized esoteric testing, employer and occupational health testing, clinical trial laboratory services and health information solutions designed to integrate lab data into provider and population health workflows. These capabilities are delivered through laboratory infrastructure, patient collection sites and digital tools that enable ordering, reporting and analytics.

Quest primarily serves the United States healthcare market—providing testing and related services to physician practices, hospitals, payers, employers and governmental agencies—while maintaining capabilities that support international clinical trials and diagnostics initiatives. The company has operated for multiple decades and is structured with centralized laboratory operations, regional service locations and an executive leadership team responsible for strategic, clinical and operational oversight.

View Quest Diagnostics Profile